Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations

Abstract Standard therapy of osteosarcoma (OS) and Ewing sarcoma (EW) rests on cytotoxic regimes, which are largely unsuccessful in advanced patients. Preclinical models are needed to break this impasse. A panel of patient-derived xenografts (PDX) was established by implantation of fresh, surgically...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Patrizia Nanni, Lorena Landuzzi, Maria Cristina Manara, Alberto Righi, Giordano Nicoletti, Camilla Cristalli, Michela Pasello, Alessandro Parra, Marianna Carrabotta, Manuela Ferracin, Arianna Palladini, Marianna L. Ianzano, Veronica Giusti, Francesca Ruzzi, Mauro Magnani, Davide Maria Donati, Piero Picci, Pier-Luigi Lollini, Katia Scotlandi
Format: article
Langue:EN
Publié: Nature Portfolio 2019
Sujets:
R
Q
Accès en ligne:https://doaj.org/article/520fd06572ac4ed78a2083b0e3a1fa0d
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!